Harshit M. Savla has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Harshit M. Savla, a Promoter of Aarti Drugs Limited, has filed an annual declaration with the stock exchanges as required under SEBI's Takeover Regulations. The declaration confirms that none of the Promoters, Promoter Group members, or Persons Acting in Concert (PACs) have created any encumbrance (such as pledge, lien, or charge) on the company's shares, directly or indirectly, during the financial year 2024-2025. The filing also includes the complete list of 42 promoter and promoter group members, comprising individuals, HUFs, trusts, and private companies. This is a routine annual compliance submission, not a new transaction or event.
This is a standard regulatory disclosure with no material impact on the stock. The fact that no shares were pledged or encumbered by the promoter group during the year is mildly reassuring for shareholders, as it signals no immediate liquidity stress or forced-selling risk from the promoter side.